Medbio expands implant molding capabilities


Medbio has announced that it has launched another dedicated implant molding cell to help expand the company’s injection molding offerings.

“We’re excited about our growth and the expanded capabilities in implantable components,” said John Woodhouse, director of sales and marketing for Medbio. “We’ve increased our capacity to meet the growing needs of our customers and we are better positioned to support the fast growing implant sector in the medical device industry.”

The expansion adds two 55-ton electric presses and Arbor’s micro molding modules to the new implant molding cell. The presses are also in an ISO class 7 cleanroom. Top-performing operators have been assigned to the new cell and are expected to receive specialized, ongoing training.

Medbio attributes continuous growth in its implantable component manufacturing for neurology and orthopedic OEMs to its newest molding capacity expansion.

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

Join us in Southern California this December for DeviceTalks West on 12/11-12/12

textadimage We've attracted a diverse group of thought leaders from some of the Golden State's best medtech companies — including Bigfoot Biomedical, BD, Alphabet's Verily, Integer, Medtronic Neurovascular, Medtronic Diabetes, Smith & Nephew and many more for DeviceTalks West.

Check out our web site for latest news on speakers, agenda and event information.

Get your tickets today! »

Speak Your Mind